Predicting distant recurrences in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 risk of recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone - Gnant, M; Filipts, M; Greil, R (Ann Oncol, 2014)
et al.